TG Therapeutics, Inc. (TGTX)
57.52
+1.52
(+2.71%)
USD |
NASDAQ |
Sep 24, 16:00
57.80
+0.28
(+0.49%)
After-Hours: 06:42
TG Therapeutics Gross Profit (Annual) : 515.57M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 515.57M |
| December 31, 2024 | 290.24M |
| December 31, 2023 | 219.11M |
| December 31, 2022 | 2.005M |
| December 31, 2021 | 5.899M |
| December 31, 2020 | -0.222M |
| December 31, 2019 | -0.13M |
| December 31, 2018 | 0.064M |
| December 31, 2017 | 0.07M |
| December 31, 2016 | 0.0894M |
| December 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2011 | 0.00 |
| December 31, 2010 | -0.0034M |
| December 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
| December 31, 2001 | 0.6294M |
| December 31, 2000 | 1.224M |
| December 31, 1999 | 0.2936M |
| December 31, 1998 | -1.436M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Krystal Biotech, Inc. | 360.36M |
| Alnylam Pharmaceuticals, Inc. | 3.032B |
| BioMarin Pharmaceutical, Inc. | 2.505B |
| Cytokinetics, Inc. | 77.91M |
| Exelixis, Inc. | 2.236B |